Rezolve AI PLC filings document a foreign private issuer that reports on Form 20-F and furnishes current information on Form 6-K. The company’s disclosures cover its AI-powered digital commerce platform, including Brain Commerce and the proprietary brainpowa large language model, as well as revenue from cloud-based software solutions and transaction-based services.
The filing record includes material-event reports, operating and financial results, material agreements, shareholder voting matters, capital-structure disclosures, governance matters, regulatory matters, and risk factors. Form 6-K exhibits may include press releases and other furnished materials that update the company’s public-company record.
Rezolve AI plc entered into a registered direct offering to sell 62,500,000 ordinary shares at $4.00 per share, for gross proceeds of $250.0 million before fees and expenses. The shares are being issued under an effective Form F-3 registration statement and related prospectus supplement, with closing expected on January 21, 2026, subject to customary conditions.
The company plans to use the net proceeds to accelerate investment in its sales organization, pursue potential accretive M&A opportunities, and for general corporate and working capital purposes. Rezolve AI agreed not to issue or agree to issue additional ordinary shares or equivalents, or file new registration statements, for 30 days after closing, subject to exceptions. Placement agents will receive a 5.0% cash fee on the aggregate gross proceeds plus up to $120,000 of legal fees and up to $10,000 of non-accountable expenses.
Rezolve AI plc entered into a registered direct offering to sell 62,500,000 ordinary shares at $4.00 per share, for gross proceeds of $250.0 million before fees and expenses. The shares are being issued under an effective Form F-3 registration statement and related prospectus supplement, with closing expected on January 21, 2026, subject to customary conditions.
The company plans to use the net proceeds to accelerate investment in its sales organization, pursue potential accretive M&A opportunities, and for general corporate and working capital purposes. Rezolve AI agreed not to issue or agree to issue additional ordinary shares or equivalents, or file new registration statements, for 30 days after closing, subject to exceptions. Placement agents will receive a 5.0% cash fee on the aggregate gross proceeds plus up to $120,000 of legal fees and up to $10,000 of non-accountable expenses.
Rezolve AI plc has agreed to sell 37,000,000 ordinary shares to qualified institutional investors in a private placement at $5.40 per share. This pricing implies aggregate gross proceeds of about $200 million, before placement agent fees and other offering costs. The closing is expected on or about September 25, 2025, subject to customary closing conditions.
The company plans to use the new capital to accelerate investment in its sales organization, pursue potential accretive M&A opportunities, and support working capital and general corporate purposes. A.G.P./Alliance Global Partners is acting as lead agent and H.C. Wainwright & Co. as co-lead agent for the transaction, which is being conducted under U.S. private placement exemptions and is not registered under the Securities Act.
Rezolve AI plc reports that holders of all 5,000,000 warrants issued in a registered offering in December 2024 have exercised their warrants. Each warrant was exercised at $3.00 for one ordinary share, resulting in 5,000,000 new ordinary shares and generating aggregate gross proceeds of $15 million for the company. The early expiration date of these warrants was triggered after the company’s share VWAP stayed at or above $6.00 for five consecutive trading days in September.